Currently out of the existing stock ratings of John Young, 19 are a HOLD (35.85%), 34 are a BUY (64.15%).

John Young

Work Performance Price Targets & Ratings Chart

Analyst John Young, currently employed at CANACCORD, carries an average stock price target met ratio of 35.05% that have a potential upside of 26.15% achieved within 80 days.

John Young’s has documented 105 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ANGO, AngioDynamics at 09-Oct-2026.

Wall Street Analyst John Young

Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 2/27/2024. The price target of $32 was fulfilled within 1 day with a profit of $0.68 (2.08%) receiving and performance score of 20.81.

Average potential price target upside

LUNG Pulmonx Corp STAA STAAR Surgical Company ANGO AngioDynamics MMSI Merit Medical Systems

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Oct-2020

$4

$1.48 (58.73%)

$5

Buy Since 10-Mar-2025

$14

$12.75 (1020.00%)

5 months 29 days ago
(30-Apr-2026)

0/3 (0%)

$12.72 (993.75%)

Buy Since 31-Oct-2023

$5

$3.75 (300.00%)

$15

7 months 24 days ago
(05-Mar-2026)

1/8 (12.5%)

$3.39 (210.56%)

43

Buy Since 04-Jun-2024

$4

$2.75 (220.00%)

$12

1 years 1 days ago
(28-Oct-2025)

0/2 (0%)

$2.02 (102.02%)

Buy Since 10-Dec-2021

$2.5

$1.25 (100.00%)

1 years 2 months 28 days ago
(31-Jul-2025)

4/12 (33.33%)

$0.66 (35.87%)

92

Show more analysts

Please expand the browser size to see the chart

Which stock is John Young most bullish on?

Potential upside of $9.39 has been obtained for STAA (STAAR SURGICAL COMPANY)

Which stock is John Young most reserved on?

Potential downside of $7.63 has been obtained for ANGO (ANGIODYNAMICS)

What Year was the first public recommendation made by John Young?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?